| __timestamp | Supernus Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 5758000 | 9216000000 |
| Thursday, January 1, 2015 | 8423000 | 8296000000 |
| Friday, January 1, 2016 | 11986000 | 10044000000 |
| Sunday, January 1, 2017 | 15215000 | 11560000000 |
| Monday, January 1, 2018 | 15356000 | 10558000000 |
| Tuesday, January 1, 2019 | 16660000 | 9351000000 |
| Wednesday, January 1, 2020 | 52459000 | 8933000000 |
| Friday, January 1, 2021 | 75061000 | 8284000000 |
| Saturday, January 1, 2022 | 87221000 | 7952000000 |
| Sunday, January 1, 2023 | 83779000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the cost of revenue is crucial for assessing a company's financial health. This analysis focuses on Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc., two prominent players in the sector. Over the past decade, Teva's cost of revenue has shown a downward trend, decreasing by approximately 14% from 2014 to 2023. In contrast, Supernus has experienced a staggering 1,355% increase in the same period, reflecting its aggressive growth strategy.
Teva, a global leader, faced challenges in maintaining its cost efficiency, with its highest cost recorded in 2017. Meanwhile, Supernus, a smaller yet dynamic company, saw its cost of revenue peak in 2022, indicating its expanding market presence. This juxtaposition highlights the diverse strategies and market dynamics within the pharmaceutical industry, offering valuable insights for investors and industry analysts alike.
Cost of Revenue Comparison: Sanofi vs Supernus Pharmaceuticals, Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: United Therapeutics Corporation vs Supernus Pharmaceuticals, Inc.
Catalent, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Exelixis, Inc. vs Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Veracyte, Inc. and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.'s Expenses